The art and science of switching antipsychotic medications, part 2.

Peter J. Weiden, Alexander L. Miller, Tim J. Lambert, Peter F. Buckley

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

In the presentation "Switching and Metabolic Syndrome," Weiden summarizes reasons to switch antipsychotics, highlighting weight gain and other metabolic adverse events as recent treatment targets. In "Texas Medication Algorithm Project (TMAP)," Miller reviews the TMAP study design, discusses results related to the algorithm versus treatment as usual, and concludes with the implications of the study. Lambert's presentation, "Dosing and Titration Strategies to Optimize Patient Outcome When Switching Antipsychotic Therapy," reviews the decision-making process when switching patients' medication, addresses dosing and titration strategies to effectively transition between medications, and examines other factors to consider when switching pharmacotherapy.

Original languageEnglish (US)
Pages (from-to)e02
JournalThe Journal of clinical psychiatry
Volume68
Issue number1
Publication statusPublished - Jan 2007

    Fingerprint

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Weiden, P. J., Miller, A. L., Lambert, T. J., & Buckley, P. F. (2007). The art and science of switching antipsychotic medications, part 2. The Journal of clinical psychiatry, 68(1), e02.